Analysts think SNOA stock price could increase by 294%
Aug 01, 2024, 6:26 AM
0.00%
What does SNOA do
Sonoma Pharmaceuticals, Inc., based in Boulder, Colorado, specializes in producing hypochlorous acid products for various health care uses, including wound and animal care, and has 8 full-time employees. Its key products include Regenacyn Advanced Scar Gel, MicrocynAH for animal wounds, and several other care gels and cleansers launched after its 2007 IPO.
3 analysts think SNOA stock price will increase by 294.03%. The current median analyst target is $1.53 compared to a current stock price of $0.39. The lowest analysts target is $1.52 and the highest analyst target is $1.58.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
